Getting paid: New pre-auth, non-coverage policies may be in your future for HA injections

Why This Topic Matters

Coverage shifts for commonly used orthopedic therapies can affect patient access, practice revenue, and administrative workload. Understanding the policy environment helps practices anticipate payer requirements and monitor related coding and documentation implications.

Article Sections

1. Coverage changes affecting hyaluronic acid injections

   Introduces recent payer policy changes that affect orthopedic injection services and describes the operational impact on practices and patients.

2. AAOS guideline initiates changes

   Summarizes how professional society guidance is being cited in payer policy updates and discusses the broader payer response landscape.

3. Guidelines meant for docs, not payers

   Explains the distinction between clinical practice guidance and payer coverage determinations, including how policies may interpret society recommendations.

4. AAOS: Eliminate 'publication bias'

   Discusses the evidence-review context behind the guideline process and the role of study quality and publication patterns in shaping recommendations.

5. Welcome to evidence-based medicine

   Addresses the move toward outcomes tracking, registry participation, and evidence-supported orthopedic care in future reimbursement environments.